Literature DB >> 2576479

Trilateral retinoblastoma in transgenic mice.

J M O'Brien, D M Marcus, A S Niffenegger, R Bernards, J L Carpenter, J J Windle, P Mellon, D M Albert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2576479      PMCID： PMC1298548     

Source DB:  PubMed          Journal:  Trans Am Ophthalmol Soc        ISSN： 0065-9533


× No keyword cloud information.
  49 in total

1.  Mice transgenic for a vasopressin-SV40 hybrid oncogene develop tumors of the endocrine pancreas and the anterior pituitary. A possible model for human multiple endocrine neoplasia type 1.

Authors:  D Murphy; A Bishop; G Rindi; M N Murphy; G W Stamp; J Hanson; J M Polak; B Hogan
Journal:  Am J Pathol       Date:  1987-12       Impact factor: 4.307

2.  Pancreatic neoplasia induced by SV40 T-antigen expression in acinar cells of transgenic mice.

Authors:  D M Ornitz; R E Hammer; A Messing; R D Palmiter; R L Brinster
Journal:  Science       Date:  1987-10-09       Impact factor: 47.728

3.  Cell-division sequence motif.

Authors:  J Figge; T F Smith
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

Review 4.  Molecular associations and conceptual connections.

Authors:  M Robertson
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

5.  A retrovirus expressing the 12S adenoviral E1A gene product can immortalize epithelial cells from a broad range of rat tissues.

Authors:  R D Cone; T Grodzicker; M Jaramillo
Journal:  Mol Cell Biol       Date:  1988-03       Impact factor: 4.272

6.  Association between an oncogene and an anti-oncogene: the adenovirus E1A proteins bind to the retinoblastoma gene product.

Authors:  P Whyte; K J Buchkovich; J M Horowitz; S H Friend; M Raybuck; R A Weinberg; E Harlow
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

7.  A region of SV40 large T antigen can substitute for a transforming domain of the adenovirus E1A products.

Authors:  E Moran
Journal:  Nature       Date:  1988-07-14       Impact factor: 49.962

8.  Unexpected thymic hyperplasia in transgenic mice harboring a neuronal promoter fused with simian virus 40 large T antigen.

Authors:  F M Botteri; H van der Putten; D F Wong; C A Sauvage; R M Evans
Journal:  Mol Cell Biol       Date:  1987-09       Impact factor: 4.272

9.  The retinoblastoma susceptibility gene encodes a nuclear phosphoprotein associated with DNA binding activity.

Authors:  W H Lee; J Y Shew; F D Hong; T W Sery; L A Donoso; L J Young; R Bookstein; E Y Lee
Journal:  Nature       Date:  1987 Oct 15-21       Impact factor: 49.962

10.  The human papillomavirus type 16 E7 gene encodes transactivation and transformation functions similar to those of adenovirus E1A.

Authors:  W C Phelps; C L Yee; K Münger; P M Howley
Journal:  Cell       Date:  1988-05-20       Impact factor: 41.582
View more
  4 in total

1.  Transgenic models of retinoblastoma: what they tell us about its cause and treatment.

Authors:  D M Albert; A E Griep; P F Lambert; K A Howes; J J Windle; J G Lasudry
Journal:  Trans Am Ophthalmol Soc       Date:  1994

Review 2.  Applications of monoclonal antibodies in the investigation, diagnosis, and treatment of retinoblastoma.

Authors:  J F Tarlton; D L Easty
Journal:  Br J Ophthalmol       Date:  1993-12       Impact factor: 4.638

3.  Neuronal and glial properties of a murine transgenic retinoblastoma model.

Authors:  T Kivelä; I Virtanen; D M Marcus; J M O'Brien; J L Carpenter; E Brauner; A Tarkkanen; D M Albert
Journal:  Am J Pathol       Date:  1991-05       Impact factor: 4.307

4.  Lack of effect of SU1498, an inhibitor of vascular endothelial growth factor receptor-2, in a transgenic murine model of retinoblastoma.

Authors:  C M Cebulla; M E Jockovich; H Boutrid; Y Piña; M Ruggeri; S Jiao; S K Bhattacharya; W J Feuer; T G Murray
Journal:  Open Ophthalmol J       Date:  2008-04-02
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.